Breaking News: WeedMD Reports Fiscal Year 2018 Financial Results

WeedMD Inc. (TSX-V: WMD) (OTCQX: WDDMF) (FSE: 4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report its financial results for the fourth quarter and fiscal year ending December 31, 2018.

WeedMD reports revenues of $8.2M in its second year of operations representing a year-over-year increase of 465%. Revenues were driven by a combination of increased cannabis sales to medical patients, supply agreements for Canada’s adult-use market in addition to the sale of wholesale cannabis and genetics to other licensed producers. The Company is well financed with a strong cash balance of $21.2M as of December 31, 2018.

For the years ended December 31 2018 2017
($) ($)
Revenue 8,203,273 1,451,062
Net and Comprehensive Loss (895,128) (8,805,222)
Adjusted Operating Loss* (11,737,061) (7,042,047)
Cash Used from Operations (615,514) (2,986,928)
Earnings (Loss) per Share (Basic and Fully Diluted) (0.01) (0.15)
As at December 31, 2018 December 31, 2017
  ($) ($)
Cash and Cash Equivalents 21,223,641 24,695,152
Total Assets 88,068,657 39,605,187
Total Liabilities 10,976,340 14,472,639
Working Capital 29,838,984 25,713,807
*Adjusted Operating Loss is not a recognized measurement under IFRS and this data may not be comparable to data presented by other companies. Management believes Adjusted Operating Loss to be an important measure of the Company’s day-to-day operations, by excluding non-cash gains and losses and/or non-recurring items.

Corporate Highlights Fiscal Year 2018

Corporate Milestones

  • closed a $34.5M bought deal equity financing
  • entered into a joint venture with Phivida Holdings Inc. (CSE:VIDA) to manufacture and produce cannabis-infused beverages
  • completed strategic partnership with TruTrace Technologies Inc. (TSXV:TTT) (formerly Blockstrain Technology Corp.)
  • interlisted on OTCQX® Best Market and secured Depository Trust Company (“DTC”) eligibility and commenced trading under the ticker symbol (OTXQX:WDDMF)

Production-Related Milestones

  • completed the retrofit and licensing of Phase I, initial 44,000 square feet of the Strathroy greenhouse in June 2018, with successful initial harvest in September 2018
  • secured a Health Canada sales licence for its Strathroy greenhouse
  • obtained approval from Health Canada for six additional 10,000 sq. ft. rooms at Strathroy greenhouse in December 2018, with first harvests beginning in March 2019

Sales, Marketing & Business Development Milestones

  • commenced sales of cannabis oil products under Entourage and Axis brands
  • registered WeedMD’s strains under a comprehensive cannabis genetics archiving platform as the pilot for TruTrace’s cannabis validation program
  • executed supply arrangements with four provinces and completed first shipments to Ontario Cannabis Retail Corporation (“OCRC”) – operating as the Ontario Cannabis Store (“OCS”), Alberta Gaming, Liquor & Cannabis Commission (“AGLC”), British Columbia Liquor Distribution Branch (“BCLDB”), Nova Scotia Liquor Corporation (“NSLC”)
  • exported our world-class cannabis genetics internationally to both Australia and Israel
  • announced a retail sales distribution agreement with Lifford Cannabis Solutions, led by cannabis advocate, influencer and media personality Lisa Campbell, for British Columbia and Alberta
  • entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart
  • delivered first shipments of WeedMD-branded cannabis for the launch of adult-use market on October 17, 2018

Key Leadership Appointments

  • appointed Keith Merker as CEO (formerly CFO)
  • appointed Kevin McGovern, Chairman of McGovern Capital and founder of the beverage company SoBe, the fastest growing beverage company in the US as Board Director
  • appointed Dr. Jonas Vanderzwan, a physician with more than 15 years of primary care experience as Medical Director and Chair of the Clinical Advisory Board
  • appointed Michael Pesner, President of Hermitage Canada Finance Inc. and previously partner at KPMG for 26 years, as Board Director and Chair of Audit Committee
  • expanded senior leadership team with the following hires in 2018:
    °  Nichola Thompson, CFO (interim CFO in 2018, affirmed as CFO April 2019)
    °  Josephine DesLauriers, Senior Vice President, People
    °  
    Brett Moon, Senior Vice President, Sales & Marketing
    °  
    Marianella delaBarrera, Vice President, Communications & Corporate Affairs
    °  
    Derek Pedro, Chief Cannabis Officer (announced in March 2019)

    °  Alex Sibilev, Vice President, Compliance and Global Regulatory Affairs (announced in March 2019)

Subsequent Events

  • announced outdoor cannabis cultivation at its licensed 98-acre Strathroy Property
  • submitted an amendment to existing licence to include initial Phase I, 25-acre outdoor grow
  • entered into a $39M debt facility with BMO and purchased the 98-acre Strathroy property including indoor greenhouse, land and infrastructure
  • purchased 60 acres of land directly adjacent to Strathroy property for outdoor cultivation for up to 110 acres or more than 100,000 kgs by 2020
  • secured Health Canada Standard Processing Licence for Strathroy facility
  • announced partnership with Pita Pit to launch Pioneer Cannabis Co. (“Pioneer”), a retail cannabis platform for Ontario and rest of Canada
  • secured approval to supply cannabis to two further provinces – Manitoba Liquor & Lotteries Corporation (“MBLL”) and Saskatchewan Liquor & Gaming Authority (“SLGA”)
  • Pioneer signed agreement with Ontario cannabis retail lottery winner and operator to open its first store in Burlington, Ontario
  • expanded corporate footprint with offices in downtown Toronto and London, Ontario to drive commercial growth

Greenhouse Construction Timetable

The ramp up of the Strathroy facility continues on schedule as follows:

  • as of December 31, 2018, the Company had secured cultivation licences for Phase 1 and Phase II, providing 110,000 sq. ft. of production space with 10 hybrid-greenhouse cultivation rooms, including clone and vegetation rooms, in full cultivation
  • submitted an amendment to Strathroy licence for Phase III of its expansion, including licensing an additional 10 rooms, or 110,000 sq. ft. of production space, expecting to begin cultivation in June 2019
  • anticipates completion of Phase IV construction of two large greenhouse rooms by end of Q2-2019, adding a further 308,000 sq. ft. of cultivation capacity and planning to plant and harvest in 2019
  • on March 27, 2019, announced plans to launch outdoor cultivation on its 98-acre Strathroy property with plans to grow on 27 acres of workable land to be planted in June and harvested in Fall 2019 and an additional 23 acres in 2020
  • on April 10, 2019, subsequently announced the purchase of an additional 60 acres of adjacent land bringing total planned outdoor cultivation space to more than 100 acres or 100,000 kgs in 2020

Strathroy Cultivation Expansion & 2019 Harvest Schedule

Indoor Production
Type
Expected Construction
Completion
Licence Issue Date
(or expected)
Production
Space (Sq Ft)
Measurement # of Rooms Licences
Phase 1 Hybrid GH Complete June  2018 44,000 Sq Ft 4 Cultivation, Sale
Phase 2 Hybrid GH Complete December 2018 66,000 Sq Ft 6 Cultivation, Sale
Phase 3 Hybrid GH March 2019 June 2019 (expected) 110,000 Sq Ft 10 Amendment submitted
Phase 4 Standard GH June 2019 Q3 2019 (expected) 308,000 Sq Ft 2 Amendment to existing licence
Total Indoor       528,000   22  
Outdoor Expected Construction
Completion
Licence Issue Date 
(or expected)
Cultivation
Space (Sq Ft)
Cultivation
Space (Acres)
Cultivation
Zones
Licences
Phase 1 Outdoor May 2019 June 2019 (expected) 1,100,000 27 1 Amendment to existing licence
Phase 2 Outdoor Q2 2020 Q2 2020 (expected) 3,200,000 73 3 Amendment to existing licence
Total Outdoor       4,300,000 100 4  
Consolidated       4,828,000 112    

“Our team achieved a number of key milestones in 2018 as we rapidly built out and licensed our industry-leading production platform in record time to address the onset of the adult-use market. We signed key supply agreements with six provinces and added Shoppers Drug Mart to our distribution network. With our focus on operational excellence, we added key members to round out a formidable leadership team,” said Keith Merker, CEO of WeedMD. “Our solid base of operations and rapidly expanding production platforms sets the pace for completing our build out this year. With our greenhouse and outdoor platforms, WeedMD is well-positioned for very significant organic growth in 2019. We look forward to taking WeedMD to the next level with the launch of new brands, the roll out of new products, the build out of an international presence in addition to expanding our extraction and processing operations whilst exploring M&A opportunities to drive shareholder value.”

The Company’s financial statements and related management’s discussion and analysis for the period are available under the Company’s profile on SEDAR at www.sedar.com. All amounts are expressed in Canadian dollars and are in accordance with International Financial Reporting Standards unless otherwise noted.

For more information, access WeedMD’s investor presentation here and recently updated corporate video here.

About WeedMD Inc.
WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and distributor of cannabis products for both the medical and adult-use markets. The Company owns and operates two facilities: a 26,000 sq. ft. indoor facility in Aylmer, Ontario and a 158-acre state-of-the-art greenhouse and outdoor facility located in Strathroy, Ontario. The Company currently has 136,000 square feet of licensed production space across its facilities and is expected to have a total footprint of more than 550,000 square feet of indoor and greenhouse production in addition to more than 25 acres of outdoor cultivation space online in the first half of 2019. WeedMD has a multi-channeled distribution strategy that includes selling directly to medical patients, strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies.

Sponsored Content Release. Click for Full Disclosure

1 Comment
  1. Ingmar M. 2 months ago
    Reply

    medical patients will only continu to increase as many are sampling cannabis as an opioid alternative

Leave a Comment

  • Sponsored Content Release

    FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For WeedMD Inc. financial and corporate news dissemination, FinancialBuzz.com has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com